SYMBION FONDEN

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.0% 0.9% 0.9% 0.9% 1.0%  
Credit score (0-100)  87 89 88 88 85  
Credit rating  A A A A A  
Credit limit (kDKK)  1,235.3 1,604.9 1,595.5 1,455.9 1,313.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  399 402 403 413 456  
Gross profit  367 370 370 380 423  
EBITDA  367 370 370 380 423  
EBIT  367 370 370 380 423  
Pre-tax profit (PTP)  357.6 362.6 364.8 375.6 434.0  
Net earnings  357.6 362.6 364.8 375.6 434.0  
Pre-tax profit without non-rec. items  358 363 365 376 434  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  21,691 21,154 21,119 21,494 21,928  
Interest-bearing liabilities  27.5 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  21,824 22,178 21,242 21,576 22,015  

Net Debt  -1,434 -1,340 -880 -1,214 -1,653  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  399 402 403 413 456  
Net sales growth  0.8% 0.7% 0.2% 2.6% 10.3%  
Gross profit  367 370 370 380 423  
Gross profit growth  0.8% 0.7% 0.1% 2.6% 11.3%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  21,824 22,178 21,242 21,576 22,015  
Balance sheet change%  0.5% 1.6% -4.2% 1.6% 2.0%  
Added value  367.3 370.0 370.5 380.0 423.0  
Added value %  91.9% 92.0% 91.9% 91.9% 92.8%  
Investments  0 0 0 0 0  

Net sales trend  2.0 3.0 4.0 5.0 5.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  91.9% 92.0% 91.9% 91.9% 92.8%  
EBIT %  91.9% 92.0% 91.9% 91.9% 92.8%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  89.5% 90.2% 90.5% 90.9% 95.2%  
Profit before depreciation and extraordinary items %  89.5% 90.2% 90.5% 90.9% 95.2%  
Pre tax profit less extraordinaries %  89.5% 90.2% 90.5% 90.9% 95.2%  
ROA %  1.7% 1.7% 1.7% 1.8% 2.0%  
ROI %  1.7% 1.7% 1.8% 1.8% 2.0%  
ROE %  1.7% 1.7% 1.7% 1.8% 2.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  99.4% 95.4% 99.4% 99.6% 99.6%  
Relative indebtedness %  33.1% 254.5% 30.7% 19.8% 19.1%  
Relative net indebtedness %  -332.7% -78.7% -187.7% -273.8% -343.3%  
Net int. bear. debt to EBITDA, %  -390.4% -362.2% -237.6% -319.5% -390.6%  
Gearing %  0.1% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  70.7% 53.9% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  11.0 1.8 7.1 14.8 19.0  
Current Ratio  11.0 1.8 7.1 14.8 19.0  
Cash and cash equivalent  1,461.5 1,340.2 880.1 1,214.0 1,652.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  365.9% 451.4% 218.4% 293.6% 362.5%  
Net working capital  1,329.1 791.7 756.5 1,132.1 1,566.1  
Net working capital %  332.7% 196.9% 187.7% 273.8% 343.4%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0